Denali Therapeutics | 144:擬議出售證券
Denali Therapeutics | 4:持股變動聲明-董事 SATO VICKI L
Denali Therapeutics | 144:擬議出售證券
Denali Therapeutics | 4:持股變動聲明-董事 SATO VICKI L
Denali Therapeutics | 4:持股變動聲明-董事 Krognes Steve E.
Denali Therapeutics | 4:持股變動聲明-高管 Schuth Alexander O.
Denali Therapeutics | 4:持股變動聲明-高管 Watts Ryan J.
Denali Therapeutics | 4:持股變動聲明-高管 Ho Carole
Denali Therapeutics | 144:擬議出售證券
Denali Therapeutics | 144:擬議出售證券
Denali Therapeutics | 144:擬議出售證券
Denali Therapeutics | 144:擬議出售證券
Denali Therapeutics | 144:擬議出售證券
Denali Therapeutics | 144:擬議出售證券
Denali Therapeutics | 144:擬議出售證券
Denali Therapeutics | SC 13G:超過5%持股股東披露文件-FMR LLC(5.023%),Abigail P. Johnson(5.023%)
Denali Therapeutics | 4:持股變動聲明-高管 Schuth Alexander O.
Denali Therapeutics | 4:持股變動聲明-高管 Ho Carole
Denali Therapeutics | 144:擬議出售證券
Denali Therapeutics | 144:擬議出售證券
暫無數據
暫無數據